Reata Pharmaceuticals, Inc.
RETA · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $192,998 | -$116,117 | -$85,502 | -$79,002 |
| Dep. & Amort. | $293 | $288 | $277 | $272 |
| Deferred Tax | -$291,965 | $0 | $0 | $0 |
| Stock-Based Comp. | $20,363 | $38,057 | $14,977 | $14,446 |
| Change in WC | $1,674 | -$12,741 | $10,980 | $7,929 |
| Other Non-Cash | $6,709 | $9,064 | $8,842 | $9,821 |
| Operating Cash Flow | -$69,928 | -$81,449 | -$50,426 | -$46,534 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$274 | -$141 | -$367 | -$341 |
| Net Acquisitions | $0 | $0 | $75,000 | $0 |
| Inv. Purchases | -$240,092 | -$63,864 | -$184,127 | -$143,797 |
| Inv. Sales/Matur. | $197,420 | $175,000 | $245,000 | $0 |
| Other Inv. Act. | $0 | $0 | -$75,000 | $75,000 |
| Investing Cash Flow | -$42,946 | $110,995 | $60,506 | -$69,138 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $109,232 | $1 | $0 | $113,496 |
| Stock Repurch. | $22,648 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $13,082 | $314 | $436 |
| Financing Cash Flow | $76,777 | $13,082 | $314 | $436 |
| Forex Effect | $167,977 | $0 | $0 | $0 |
| Net Chg. in Cash | -$36,097 | $42,628 | $10,394 | -$115,236 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $84,940 | $42,312 | $31,918 | $147,154 |
| End Cash | $48,843 | $84,940 | $42,312 | $31,918 |
| Free Cash Flow | -$70,202 | -$81,590 | -$50,793 | -$46,875 |